
MorphoSys AG
XETRA:MOR

Intrinsic Value
The intrinsic value of one
MOR
stock under the Base Case scenario is
16.41
EUR.
Compared to the current market price of 67.25 EUR,
MorphoSys AG
is
Overvalued by 76%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
MorphoSys AG
Fundamental Analysis


Revenue & Expenses Breakdown
MorphoSys AG
Balance Sheet Decomposition
MorphoSys AG
Current Assets | 675m |
Cash & Short-Term Investments | 630.8m |
Receivables | 30.8m |
Other Current Assets | 13.4m |
Non-Current Assets | 1.2B |
Long-Term Investments | 2.1m |
PP&E | 11m |
Intangibles | 1.1B |
Other Non-Current Assets | 7.3m |
Free Cash Flow Analysis
MorphoSys AG
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
MorphoSys AG
Revenue
|
203.5m
EUR
|
Cost of Revenue
|
-32.8m
EUR
|
Gross Profit
|
170.7m
EUR
|
Operating Expenses
|
-611.1m
EUR
|
Operating Income
|
-440.4m
EUR
|
Other Expenses
|
-19.9m
EUR
|
Net Income
|
-460.3m
EUR
|
MOR Profitability Score
Profitability Due Diligence
MorphoSys AG's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Score
MorphoSys AG's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
MOR Solvency Score
Solvency Due Diligence
MorphoSys AG's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Score
MorphoSys AG's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MOR Price Targets Summary
MorphoSys AG
Dividends
Current shareholder yield for MOR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MOR
stock under the Base Case scenario is
16.41
EUR.
Compared to the current market price of 67.25 EUR,
MorphoSys AG
is
Overvalued by 76%.